Monotherapy dose escalation clinical and translational data from first-in-human study in advanced solid tumors of IPI-549, an oral, selective, PI3K-gamma inhibitor targeting tumor macrophages Meeting Abstract

  

Authors:	Hong, D.; Tolcher, A.; Sullivan, R.; Shapiro, G.; Chmielowski, B.; Ribas, A.; Brail, L.; Pearlberg, J.; Mahabhashyam, S.; Lee, L.; Ullmann, C. D.; O'Connell, B.; Kutok, J.; Postow, M.; Wolchok, J.
Abstract Title:	Monotherapy dose escalation clinical and translational data from first-in-human study in advanced solid tumors of IPI-549, an oral, selective, PI3K-gamma inhibitor targeting tumor macrophages
Meeting Title:	32nd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2017)
Journal Title:	Journal for ImmunoTherapy of Cancer
Volume:	5
Issue:	Suppl. 3
Meeting Dates:	2017 Nov 8-12
Meeting Location:	National Harbor, MD
ISSN:	2051-1426
Publisher:	Biomed Central Ltd
Date Published:	2017-12-07
Start Page:	89
Language:	English
DOI:	10.1186/s40425-017-0297-3
PROVIDER:	manual
Notes:	Meeting Abstract: O43 -- Late-breaking abstract

https://synapse.mskcc.org/synapse/works/has_related_data_chk/143314